Advertisement
PUNE, India, April 18, 2016 /PRNewswire-iReach/ -- The report "IgE Allergy Blood Tests - Medical Devices Pipeline Assessment, 2016" provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key IgE Allergy Blood Tests pipeline products.
Photo - http://photos.prnewswire.com/prnh/20160415/355895LOGO
Access a Report Copy @ https://www.wiseguyreports.com/reports/ige-allergy-blood-tests-medical-devices-pipeline-assessment-2016 .
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the IgE Allergy Blood Tests under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of IgE Allergy Blood Tests and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry
Reasons to buy
The report enables you to - - Formulate significant competitor information, analysis, and insights to improve R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of IgE Allergy Blood Tests under development - Develop market-entry and market expansion strategies - Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline - In-depth analysis of the product's current stage of development, territory and estimated launch date
Purchase a 1-User License Copy @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=403216 .
Major Points in Table of Content
1 Table of Contents 2 1.1 List of Tables 4 1.2 List of Figures 5 2 Introduction 6 2.1 IgE Allergy Blood Tests Overview 6 3 Products under Development 7 3.1 IgE Allergy Blood Tests - Pipeline Products by Stage of Development 7 3.2 IgE Allergy Blood Tests - Pipeline Products by Territory 8 3.3 IgE Allergy Blood Tests - Pipeline Products by Regulatory Path 9 3.4 IgE Allergy Blood Tests - Pipeline Products by Estimated Approval Date 10 4 IgE Allergy Blood Tests - Pipeline Products under Development by Companies 11 4.1 IgE Allergy Blood Tests Companies - Pipeline Products by Stage of Development 11 4.2 IgE Allergy Blood Tests - Pipeline Products by Stage of Development 12 5 IgE Allergy Blood Tests Companies and Product Overview 13 5.1 Abionic SA Company Overview 13 5.1.1 Abionic SA Pipeline Products & Ongoing Clinical Trials Overview 13 5.2 Amerimmune Company Overview 15 5.2.1 Amerimmune Pipeline Products & Ongoing Clinical Trials Overview 15 5.3 Atomo Diagnostics Pty Limited Company Overview 17 5.3.1 Atomo Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview 17 5.4 AXO Science S.A.S. Company Overview 18 5.4.1 AXO Science S.A.S. Pipeline Products & Ongoing Clinical Trials Overview 18 5.5 Biovator AB Company Overview 20 5.5.1 Biovator AB Pipeline Products & Ongoing Clinical Trials Overview 20 5.6 Children's Hospital Boston Company Overview 21 5.6.1 Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 21 5.7 China Medical Technologies, Inc. Company Overview 23 5.7.1 China Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23 5.8 Cytognos, S.L. Company Overview 25 5.8.1 Cytognos, S.L. Pipeline Products & Ongoing Clinical Trials Overview 25 5.9 HOB Biotech Group Co., Ltd. Company Overview 26 5.9.1 HOB Biotech Group Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 26 5.10 Hycor Biomedical Inc. Company Overview 27 5.10.1 Hycor Biomedical Inc. Pipeline Products & Ongoing Clinical Trials Overview 27 5.11 Institut fur Produktqualitat GmbH Company Overview 30 5.11.1 Institut fur Produktqualitat GmbH Pipeline Products & Ongoing Clinical Trials Overview 30 5.12 The Binding Site Group Ltd. Company Overview 31 5.12.1 The Binding Site Group Ltd. Pipeline Products & Ongoing Clinical Trials Overview 31 5.13 The University of Queensland Company Overview 32 5.13.1 The University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 32 5.14 University of Connecticut Health Center Company Overview 33 5.14.1 University of Connecticut Health Center Pipeline Products & Ongoing Clinical Trials Overview 33 5.15 University of Nottingham Company Overview 34 5.15.1 University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 34 5.16 VEGA Ltd Company Overview 36 5.16.1 VEGA Ltd Pipeline Products & Ongoing Clinical Trials Overview 36 6 IgE Allergy Blood Tests- Recent Developments 37 7 Appendix 38 7.1 Methodology 38 7.2 About GlobalData 40 7.3 Contact Us 41 7.4 Disclaimer 41
Inquire for more information @ https://www.wiseguyreports.com/enquiry/ige-allergy-blood-tests-medical-devices-pipeline-assessment-2016 .
Contact for More Information at [email protected] or +1 (646) 845 9349 (US) and +44 208 133 9349 (UK)
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.
Media Contact: Norah Trent, WiseGuy Reports, +1 646 845 9349, [email protected]
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE WiseGuy Reports
Advertisement
Photo - http://photos.prnewswire.com/prnh/20160415/355895LOGO
Access a Report Copy @ https://www.wiseguyreports.com/reports/ige-allergy-blood-tests-medical-devices-pipeline-assessment-2016 .
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the IgE Allergy Blood Tests under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of IgE Allergy Blood Tests and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry
Reasons to buy
The report enables you to - - Formulate significant competitor information, analysis, and insights to improve R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of IgE Allergy Blood Tests under development - Develop market-entry and market expansion strategies - Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline - In-depth analysis of the product's current stage of development, territory and estimated launch date
Purchase a 1-User License Copy @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=403216 .
Major Points in Table of Content
1 Table of Contents 2 1.1 List of Tables 4 1.2 List of Figures 5 2 Introduction 6 2.1 IgE Allergy Blood Tests Overview 6 3 Products under Development 7 3.1 IgE Allergy Blood Tests - Pipeline Products by Stage of Development 7 3.2 IgE Allergy Blood Tests - Pipeline Products by Territory 8 3.3 IgE Allergy Blood Tests - Pipeline Products by Regulatory Path 9 3.4 IgE Allergy Blood Tests - Pipeline Products by Estimated Approval Date 10 4 IgE Allergy Blood Tests - Pipeline Products under Development by Companies 11 4.1 IgE Allergy Blood Tests Companies - Pipeline Products by Stage of Development 11 4.2 IgE Allergy Blood Tests - Pipeline Products by Stage of Development 12 5 IgE Allergy Blood Tests Companies and Product Overview 13 5.1 Abionic SA Company Overview 13 5.1.1 Abionic SA Pipeline Products & Ongoing Clinical Trials Overview 13 5.2 Amerimmune Company Overview 15 5.2.1 Amerimmune Pipeline Products & Ongoing Clinical Trials Overview 15 5.3 Atomo Diagnostics Pty Limited Company Overview 17 5.3.1 Atomo Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview 17 5.4 AXO Science S.A.S. Company Overview 18 5.4.1 AXO Science S.A.S. Pipeline Products & Ongoing Clinical Trials Overview 18 5.5 Biovator AB Company Overview 20 5.5.1 Biovator AB Pipeline Products & Ongoing Clinical Trials Overview 20 5.6 Children's Hospital Boston Company Overview 21 5.6.1 Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 21 5.7 China Medical Technologies, Inc. Company Overview 23 5.7.1 China Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23 5.8 Cytognos, S.L. Company Overview 25 5.8.1 Cytognos, S.L. Pipeline Products & Ongoing Clinical Trials Overview 25 5.9 HOB Biotech Group Co., Ltd. Company Overview 26 5.9.1 HOB Biotech Group Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 26 5.10 Hycor Biomedical Inc. Company Overview 27 5.10.1 Hycor Biomedical Inc. Pipeline Products & Ongoing Clinical Trials Overview 27 5.11 Institut fur Produktqualitat GmbH Company Overview 30 5.11.1 Institut fur Produktqualitat GmbH Pipeline Products & Ongoing Clinical Trials Overview 30 5.12 The Binding Site Group Ltd. Company Overview 31 5.12.1 The Binding Site Group Ltd. Pipeline Products & Ongoing Clinical Trials Overview 31 5.13 The University of Queensland Company Overview 32 5.13.1 The University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 32 5.14 University of Connecticut Health Center Company Overview 33 5.14.1 University of Connecticut Health Center Pipeline Products & Ongoing Clinical Trials Overview 33 5.15 University of Nottingham Company Overview 34 5.15.1 University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 34 5.16 VEGA Ltd Company Overview 36 5.16.1 VEGA Ltd Pipeline Products & Ongoing Clinical Trials Overview 36 6 IgE Allergy Blood Tests- Recent Developments 37 7 Appendix 38 7.1 Methodology 38 7.2 About GlobalData 40 7.3 Contact Us 41 7.4 Disclaimer 41
Inquire for more information @ https://www.wiseguyreports.com/enquiry/ige-allergy-blood-tests-medical-devices-pipeline-assessment-2016 .
Contact for More Information at [email protected] or +1 (646) 845 9349 (US) and +44 208 133 9349 (UK)
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.
Media Contact: Norah Trent, WiseGuy Reports, +1 646 845 9349, [email protected]
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE WiseGuy Reports